Newsletter Anmeldung

Newsletter Subscription

News from
Science, Economy
and the BIO.NRW network

News

BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction

BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction

The EchoLUTION Viral RNA/DNA Kit is now available for the US diagnosis market to extract nucleic acids from viral particles with a unique single-centrifugation technology, reducing processing time for in vitro diagnostic ...
Report on the BIO.NRW MEDICA Forum 2023

Report on the BIO.NRW MEDICA Forum 2023

Aspects of data-driven, integrative approaches for individually optimized medicine At this year’s BIO.NRW MEDICA Forum, the speakers gave presentations on a wide range of aspects related to data-driven, individually optimized medicine. Some ...
EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe

EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe

This year was BIO.NRW’s first time to have a stand at the European Forum For Industrial Biotechnology & The Bioeconomy (EFIB) in Rotterdam (Netherlands) on 24 and 25 October 2023. Together with ...
Report on the GMS Event 2023

Report on the GMS Event 2023

On 8 and 9 November 2023, innovative enterprises and decision makers from all sectors met at “The Greener Manufacturing Show” in Cologne to discuss topics related to a sustainable and climate-smart industry ...
New Alzheimer's drug PRI-002 receives EMA approval for Phase II study

New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study

Press release from 20 November 2023 Priavoid GmbH and PRInnovation GmbH announce today that the European Medicines Agency (EMA) has granted approval to conduct a Phase II clinical trial for the drug ...
Pioneers from NRW – Hunting the pathogen with biosensors

Pioneers from NRW – Hunting the pathogen with biosensors

In our series Pioneers from NRW, Gabriela Figueroa Miranda and Viviana Rincón Montes talk about their exciting work at Forschungszentrum Jülich. The postdocs and entrepreneurs talk about their academic careers, their stations ...

News archive

Europe’s Biotech Innovators at risk… the General Pharmaceutical Legislation must prioritise innovation

Europe’s Biotech Innovators at risk… the General Pharmaceutical Legislation must prioritise innovation

press release, 24.01.2024 EuropaBio, the association representing Europe’s biotechnology industry, has published research demonstrating the negative impact of the European ...
Loading...
Report on the BIO.NRW MEDICA Forum 2023

Report on the BIO.NRW MEDICA Forum 2023

Aspects of data-driven, integrative approaches for individually optimized medicine At this year’s BIO.NRW MEDICA Forum, the speakers gave presentations on ...
EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe

EFIB 2023: Industrial Biotechnology for a Sustainable and Resilient Global Europe

This year was BIO.NRW’s first time to have a stand at the European Forum For Industrial Biotechnology & The Bioeconomy ...
Report on the GMS Event 2023

Report on the GMS Event 2023

On 8 and 9 November 2023, innovative enterprises and decision makers from all sectors met at “The Greener Manufacturing Show” ...
The Greener Manufacturing Show in Cologne brought together sustainable ideas from NRW and beyond

The Greener Manufacturing Show in Cologne brought together sustainable ideas from NRW and beyond

The industrial sector is facing an enormous challenge: it must do without fossil fuels and fossil energy, all while establishing ...
AiCuris´ innovation accelerator AiCubator calls for innovative proposals to propel anti-infective drug development in the third round

AiCuris´ innovation accelerator AiCubator calls for innovative proposals to propel anti-infective drug development in the third round

Press release from AiCuris of 29.09.2022 The AiCubator program was launched to provide first-hand support to fuel early research projects ...
Pioneers from NRW – Dr. Rebecca Melcher, BexBioTec

Pioneers from NRW – Dr. Rebecca Melcher, BexBioTec

“The Westphalian way of comforting plants”Dr. Rebecca Melcher is the founder and CEO of BexBioTec. The biotechnology startup, which is ...
New BIO.NRW Business Angel and Investors Circle implemented (supported by CLIB)

New BIO.NRW Business Angel and Investors Circle implemented (supported by CLIB)

BIO.NRW's well-known bimonthly Business Angel and Investors Circle, which has been established for a decade to finance start-ups in biotech, ...
Post-epidemic era and digital transformation, a new platform and new opportunity for investment and cooperation of life and health companies

Post-epidemic era and digital transformation, a new platform and new opportunity for investment and cooperation of life and health companies

On the occasion of Medica (the world's largest hospital and medical technology exhibition) in Düsseldorf, some German health and medical ...
BIO.NRW Imagefilm Teaser

On January 19, 2022 – Release of the new image film for the biotechnology location NRW

In order to strengthen and further develop the biotechnology industry in North Rhine-Westphalia (NRW), the new image film for the ...
"Innovation2business.nrw" -  NRW top level research: Extended opportunities for regional companies

“Innovation2business.nrw” – NRW top level research: Extended opportunities for regional companies

As part of the innovation2business.nrw funding project of the Ministry for Economic Affairs, Innovation, Digitalization and Energy, PROvendis GmbH can ...
IC-3Rs Symposium - Follow-up report

IC-3Rs Symposium – Follow-up report

The online symposium on ‘Human-relevant models for drug research and development’, organized by the „Innovations Center 3 R Alternatives” (IC-3Rs) ...
InfanDx completes two-year follow-up study AAMBI2 of newborns with suspected perinatal asphyxia

InfanDx completes two-year follow-up study AAMBI2 of newborns with suspected perinatal asphyxia

InfanDx AG, a diagnostics company specialized in the development of biomarker-based tests, today announced the completion of recruitment for its ...
BIO.NRW on YouTube

BIO.NRW on YouTube

Many of the planned and well-known events of BIO.NRW could not be held in the usual framework due to the ...
Bayer acquires the biotech company Asklepios BioPharmaceutical to broaden its innovation base in cell and gene therapy

Bayer acquires the biotech company Asklepios BioPharmaceutical to broaden its innovation base in cell and gene therapy

Bayer AG  announced on the 26th of October the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized ...
May we introduce? Our new BIO.NRW Homepage!

May we introduce? Our new BIO.NRW Homepage!

More user-friendly, informative, modern and of course more powerful. The new BIO.NRW Homepage is now online. During the last two ...
No posts found.
No posts found.
No posts found.